BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4402605)

  • 21. [Effect of pindolol on the metabolic activities of adrenaline].
    Schmitt H; Lucet B
    C R Seances Soc Biol Fil; 1970; 164(11):2193-5. PubMed ID: 4399994
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of LB-46, a new beta adrenergic blocking agent, on pulse and blood pressure at rest and after exercise in healthy volunteers.
    Mehta AB; Cooverji ND; Agrawal AB; Shah AC; Patnekar PN; Vora DD
    J Assoc Physicians India; 1971 Nov; 19(11):765-70. PubMed ID: 4399862
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of a beta-adrenergic block with pronethalol, propranolol, hydrobutamine, C.39'089-Ba and H 56-28 on the electrocardiographic modifications of NaCl,MgCl 2 and KCl in rat].
    Marmo E; Caputi A; Fucci G; Imperatore A
    Folia Cardiol; 1969; 28():83-91. PubMed ID: 4398000
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of some beta-adrenergic blocking and other drugs on brain lactate levels following electroshock.
    Leonard BE
    Neuropharmacology; 1971 Jul; 10(4):517-20. PubMed ID: 5094312
    [No Abstract]   [Full Text] [Related]  

  • 25. The selectivity of -adrenergic compounds. II. Studies on the mimetic compound Salbutamol and the lytic compound practolol.
    Grana E; Mastelli OC; Zonta F; Lucchelli A; Santagostino MG
    Farmaco Sci; 1972 Oct; 27(10):842-54. PubMed ID: 4404432
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE; Izquierdo JA
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological aspects of oxprenolol.
    Brunner H; Hedwall PR; Maier R; Meier M
    Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
    Mazurkiewicz-Kwilecki IM; Romagnoli A
    J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of beta-adrenoreceptor blockade and nitroglycerin on myocardial oxygenation.
    Winbury MM; Weiss HR; Howe BB
    Eur J Pharmacol; 1971; 16(3):271-7. PubMed ID: 4399875
    [No Abstract]   [Full Text] [Related]  

  • 31. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Prichard BN; Aellig WH; Richardson GA
    Postgrad Med J; 1970 Nov; ():Suppl:77-85. PubMed ID: 4395464
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
    Hahn RA; Pendleton RG; Wardell JR
    J Pharmacol Exp Ther; 1968 May; 161(1):111-21. PubMed ID: 5648488
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of propranolol, INPEA, iproveratril and some 1-naphthylethylamine derivatives on the myocardial phosphorylase activity.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1970 Apr; 19(4):1221-7. PubMed ID: 4398008
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardioselective beta-adrenergic blockade.
    Fitzgerald JD
    Proc R Soc Med; 1972 Sep; 65(9):761-4. PubMed ID: 4404402
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phenbutolol (Hoe 893d), a new highly efficient -sympatholytic agent with long action duration].
    Härtfelder G; Lessenich H; Schmitt K
    Arzneimittelforschung; 1972 May; 22(5):930-2. PubMed ID: 4403127
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of propranolol upon the hemoglobin-oxygen dissociation curve.
    Pendleton RG; Newman DJ; Sherman SS; Brann EG; Maya WE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):647-56. PubMed ID: 4401159
    [No Abstract]   [Full Text] [Related]  

  • 37. Steric aspects of adrenergic drugs. 8. Optical isomers of beta adrenergic receptor antagonists.
    Patil PN
    J Pharmacol Exp Ther; 1968 Apr; 160(2):308-14. PubMed ID: 4384787
    [No Abstract]   [Full Text] [Related]  

  • 38. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
    Range H; Bischoff M; Siess M
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade.
    Nayler WG; Carson V
    Cardiovasc Res; 1973 Jan; 7(1):22-9. PubMed ID: 4144407
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of alprenolol, bunolol and propranolol on pulmonary resistance in the anaesthetized dog.
    Giles RE; Finkel MP
    Eur J Pharmacol; 1971 Oct; 16(2):155-63. PubMed ID: 4405779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.